Short Interest in EUDA Health Holdings Limited (NASDAQ:EUDA) Decreases By 37.3%

EUDA Health Holdings Limited (NASDAQ:EUDA) was the target of a significant decrease in short interest in the month of June. As of June 15th, there was short interest totaling 5,223 shares, a decrease of 37.3% from the May 31st total of 8,334 shares. Currently, 0.2% of the company’s stock are sold short. Based on an average daily volume of 4,093 shares, the days-to-cover ratio is presently 1.3 days.

EUDA Health Stock Performance

Shares of NASDAQ EUDA traded up $0.49 during trading on Thursday, reaching $14.49. The stock had a trading volume of 1,213 shares, compared to its average volume of 69,217. EUDA Health has a one year low of $5.26 and a one year high of $86.00. The stock has a market cap of $43.34 million, a PE ratio of -6.04 and a beta of 0.68. The firm’s 50 day moving average price is $14.97 and its two-hundred day moving average price is $20.96.

EUDA Health (NASDAQ:EUDA) last announced its quarterly earnings data on Tuesday, May 5th. The company reported ($0.44) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.20) by $0.76. The firm had revenue of $1.92 million for the quarter, compared to the consensus estimate of $3.90 million. On average, research analysts expect that EUDA Health will post 1.6 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have weighed in on EUDA. Zacks Research raised shares of EUDA Health from a “strong sell” rating to a “hold” rating in a research report on Friday, May 8th. Weiss Ratings cut EUDA Health from a “sell (d)” rating to a “sell (e+)” rating in a research note on Friday, May 8th. Finally, Greenridge Global lowered their price objective on EUDA Health from $120.00 to $55.00 and set a “buy” rating for the company in a research note on Monday, March 9th. One equities research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $55.00.

Institutional Investors Weigh In On EUDA Health

An institutional investor recently raised its position in EUDA Health stock. Citadel Advisors LLC boosted its holdings in EUDA Health Holdings Limited (NASDAQ:EUDA) by 57.7% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 44,631 shares of the company’s stock after acquiring an additional 16,321 shares during the period. Citadel Advisors LLC owned about 0.12% of EUDA Health worth $78,000 at the end of the most recent quarter. Institutional investors own 4.35% of the company’s stock.

About EUDA Health

EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.

EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.